EMR IBD Education Tool

The Electronic Medical Record (EMR) webpage is an innovative resource for providers to quickly access and integrate relevant inflammatory bowel diseases (IBD) education materials into individual EMR systems to provide to patients.

NEED HELP COPYING TO YOUR EMR?

Check out our instructions for copying content into your specific EMR.

Learn how to copy content »

HAVE A TOPIC SUGGESTION?

Don’t see your topic? Let us know by submitting a topic suggestion.

Submit a suggested topic »

This resource is supported by an independent medical educational grant from Nestlé Health Science.

To begin, search for the topic you're interested in. Then, follow the instructions to integrate information into your EMR system.
Topic Key: updated

Current Results: 12 entries

Modified: Published: July 1, 2022
Dear @[email protected], Your healthcare team has discussed the following subject with you: tofacitinib. Brand names include Xeljanz and Xeljanz XR. Here is some additional information regarding this medical therapy. Let us know if you have any…
Modified: Published: June 8, 2022
Dear @[email protected], Your healthcare team has discussed the following medication with you: Ozanimod.  The brand name is Zeposia.  Here is some additional information.  Let us know if you have any questions regarding this information.…
Modified: Published: June 8, 2022
Dear @[email protected], Your health care team has discussed the following subject with you: upadacitinib. The brand name is RINVOQ. Here is some additional information regarding this medical therapy. Let us know if you have any questions regarding…
Modified: Published: March 31, 2022
Dear @[email protected], Your healthcare team has discussed the following subject with you: Infliximab. The brand name is Remicade. Here is some additional information. Let us know if you have any questions regarding this information. This medication belongs…
Modified: Published: March 31, 2022
Dear @[email protected], Your healthcare team has discussed the following medical therapy with you: Ustekinumab. The brand name is Stelara. Here is some additional information. Let us know if you have any questions regarding this information.…
Modified: Published: March 28, 2022
Dear @[email protected], Your healthcare team has discussed the following subject with you: Adalimumab. The brand name is Humira. Here is some additional information. Let us know if you have any questions regarding this information. This medication…
Modified: Published: March 28, 2022
Dear @[email protected], Your healthcare team has discussed the following subject with you: Goliumab. The brand name is Simponi. Here is some additional information. Let us know if you have any questions regarding this information. This medication belongs to a…
Modified: Published: March 28, 2022
Dear @[email protected], Your healthcare team has discussed the following subject with you: Natalizumab. The brand name is Tysabri. Here is some additional information. Let us know if you have any questions regarding this information. This medication…
Modified: Published: March 28, 2022
Dear @[email protected], Your healthcare team has discussed the following subject with you: Vedolizumab. The brand name is Entyvio. Here is some additional information. Let us know if you have any questions regarding this information. This medication belongs…
Modified: Published: February 5, 2020
Dear @[email protected], Your healthcare team has discussed the following subject with you: causes of flares in inflammatory bowel disease. Here is some additional information. Let us know if you have any questions regarding this information. A flare is a…

Don't see your topic? Submit a topic suggestion»